Your browser doesn't support javascript.
loading
The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.
Zeng, Shu-Xiong; Zhu, Yanjun; Ma, Ai-Hong; Yu, Weimin; Zhang, Hongyong; Lin, Tzu-Yin; Shi, Wei; Tepper, Clifford G; Henderson, Paul T; Airhart, Susan; Guo, Jian-Ming; Xu, Chuan-Liang; deVere White, Ralph W; Pan, Chong-Xian.
Afiliação
  • Zeng SX; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • Zhu Y; Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China.
  • Ma AH; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • Yu W; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang H; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • Lin TY; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • Shi W; Department of Urology, Renmin Hospital, Wuhan University, Wuhan, Hubei Province, China.
  • Tepper CG; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • Henderson PT; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • Airhart S; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • Guo JM; Department of Urology, Xijing Hospital, The Fourth Military Medical University, Shanxi Province, China.
  • Xu CL; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • deVere White RW; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California Davis, Sacramento, California.
  • Pan CX; The Jackson Laboratory, Bar Harbor, Maine.
Clin Cancer Res ; 23(21): 6580-6591, 2017 Nov 01.
Article em En | MEDLINE | ID: mdl-28808038
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Resistencia a Medicamentos Antineoplásicos / Fosfatidilinositol 3-Quinase / Classe I de Fosfatidilinositol 3-Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Resistencia a Medicamentos Antineoplásicos / Fosfatidilinositol 3-Quinase / Classe I de Fosfatidilinositol 3-Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article